Tevogen Bio Holdings Inc.

Tevogen Bio (TVGN) Slips 0.87% to $6.82 as Shares Test Lower End of Recent Range - Reversal Setup Alerts
https://www.siam.in/ · 21 Oct 2026
UPDATE - Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of HRK Healthcare LLC
The Manila Times · 09 Oct 2026
Tevogen Regains Compliance with Nasdaq Global Market Continued Listing Requirements
GlobeNewswire · 30 Sep 2026
Nasdaq issues a decision on the $50M listing requirement for Tevogen (NASDAQ: TVGN).
Stock Titan · 30 Sep 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.